BioClinica, Inc. (NASDAQ: BIOC) will give a presentation at the upcoming Jefferies Global Healthcare Services Conference. The company's President and CEO, Mark L. Weinstein, will provide an overview on the company's suite of clinical trial services and a business update.
BioClinica has been scheduled to give their presentation on January 27th at 4:30pm (EST). The presentation will be webcast simultaneously and for replay through www.wsw.com.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, and clinical supply chain design and optimization solutions.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
